Tangle

Prescription Drug Prices

Aug 21, 2024
The Biden administration has made waves by negotiating lower prices for ten common prescription drugs, set to save Medicare an estimated $6 billion by 2026. The podcast dives into the implications of these negotiations for consumers and healthcare policy. It covers diverse perspectives on how these changes could impact pharmaceutical innovation and market dynamics. Additionally, it discusses civil liberties concerns related to government oversight in healthcare. The episode wraps up with a heartwarming story about inclusion and belonging.
Ask episode
Chapters
Transcript
Episode notes